Countering the posteradication threat of smallpox and polio

Clinical Infectious Diseases

Volumn 34, Issue 1, 2002, Pages 79-83

  Henderson, D A ^a  

^a Candler Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLIOMYELITIS VACCINE; SMALLPOX VACCINE;

ARTICLE; DEVELOPING COUNTRY; EPIDEMIC; ERADICATION THERAPY; HEALTH PROGRAM; INFECTION CONTROL; POLIOMYELITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; SMALLPOX; UNITED STATES; VACCINATION; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

BIOTERRORISM; CONTAINMENT OF BIOHAZARDS; DISEASE OUTBREAKS; HUMANS; IMMUNOTHERAPY, ACTIVE; POLIOMYELITIS; POLIOVIRUS VACCINE, ORAL; RECURRENCE; RISK FACTORS; SMALLPOX; UNITED STATES; WORLD HEALTH ORGANIZATION;

EID: 0036133713     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/323897     Document Type: Article

References (14)

1. Cost benefit analysis
2. Global eradication of poliomyelitis: Benefit-cost analysis
3. Stopping poliovirus vaccination after eradication: Issues and challenges
4. Outbreak of Poliomyelitis - Dominican Republic and Haiti, 2000-2001
5. Circulation of a type 2 vaccine-derived poliovirus, Egypt
6. Transmissibility and persistence of oral polio vaccine viruses: Implications for the global poliomyelitis eradication initiative
7. Live attenuated poliovirus vaccines
8. Paralytic disease associated with oral polio vaccines
9. Gaps in our knowledge about transmission of vaccine-derived polioviruses
10. Combination vaccines
11. Combined immunization of infants with oral and inactivated poliovirus vaccines: Results of a randomized trial in The Gambia, Oman, and Thailand
12. It is too early to stop polio vaccination